PRO-FILL 201 Comp. A

Hazard statements (CLP)

H315, H317, H319, H360, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP)] Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07 GHS09 GHS08

Signal word

Danger.

Contains

2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane;Reaction mass of 2,2'- [methylenebis(2,1-phenyleneoxymethylene)]bis(oxirane) and 2,2'- [methylenebis(4,1- phenyleneoxymethylene)]bis(oxirane) and 2-({2-[4-(oxiran-2- ylmethoxy)benzyl]phenoxy}methyl)oxirane;oxirane, mono[(C12-14- alkyloxy)methyl] derivs.

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H360 - May damage fertility or the unborn child. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P260 - Do not breathe vapours. P280 - Wear protective gloves, face protection, eye protection. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P273 - Avoid release to the environment. P405 - Store locked up. P501 - Dispose of contents to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Supplemental label elements

EUH205 - Contains epoxy constituents. May produce an allergic reaction.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0.1%. Component Substance(s) not included in the list established in 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane (1675-54-3), accordance with Article 59(1) of REACH for having Reaction mass of 2,2'-[methylenebis(2,1-phenyleneoxymethylene)]bis(oxirane) endocrine disrupting properties, or is not identified and 2,2'- as having endocrine disrupting properties in [methylenebis(4,1-phenyleneoxymethylene)]bis(oxirane) and 2-({2-[4-(oxiran-2- accordance with the criteria set out in Commission ylmethoxy)benzyl]phenoxy}methyl)oxirane. Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2: H315 Serious eye damage/eye irritation, Category 2: H319 Skin sensitisation, Category 1: H317 Reproductive toxicity, Category 1B: H360 Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available.